SCHEMBL17010771

SCHEMBL17010771

Cc1c(C)c(NCC(=O)CNC2CCN(Cc3ccc(C(N)=O)cc3)CC2)c(C)c(C)c1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.45
▸ CYP2D6 P10635 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ MCHR1 Q99705 1/20 0.42
▸ MAOB P27338 1/20 0.41
▸ PRKAA2 P54646 1/20 0.41
▸ KCNH2 Q12809 1/20 0.40
▸ CNR1 P21554 1/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ DRD4 P21917 1/20 0.40
▸ SIGMAR1 Q99720 1/20 0.40
▸ ACHE P22303 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ DPP7 Q9UHL4 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4201843 0.81 KCNH2 (0.48) GAAHTR2AMCHR1KCNH2SIGMAR1
SCHEMBL2847275 0.74 GAA (0.60) GAACYP2D6MCHR1PRKAA2KCNH2
SCHEMBL4526865 0.73 KCNH2 (0.48) HTR2AMCHR1MAOBKCNH2SIGMAR1
SCHEMBL4267387 0.70 GAA (0.64) GAAMAOBKCNH2ACHEKDM4E
SCHEMBL4209657 0.69 KCNH2 (0.53) HTR2AKCNH2SIGMAR1ACHEOPRM1
SCHEMBL4261542 0.69 GAA (0.66) GAAHTR2AMAOBPRKAA2KCNH2
SCHEMBL4259748 0.69 GAA (0.66) GAACYP2D6MAOBKCNH2KDM4E
SCHEMBL4267783 0.69 GAA (0.66) GAAHTR2AMAOBPRKAA2KCNH2
SCHEMBL4207304 0.68 KCNH2 (0.45) HTR2AKCNH2SIGMAR1ACHEKDM4E
SCHEMBL20527292 0.68 GAA (0.64) GAAHTR2AMAOBPRKAA2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154467-A1 CREATION OF VASCULARIZED BIOLOGICAL STRUCTURES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2025-05-15 — — US disclosed
US-20250092358-A1 In Vitro Breeding Systems and Methods in Livestock ABS GLOBAL, INC. (US) 2025-03-20 — — US disclosed
CN-117412668-A Livestock in vitro breeding system and method ABS全球公司 2024-01-16 — — CN disclosed
WO-2023164242-A1 CREATION OF VASCULARIZED BIOLOGICAL STRUCTURES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2023-08-31 — — WO disclosed
US-20230159894-A1 GENERATING POPULATIONS OF HUMAN BLOOD AND BLOOD VESSEL PROGENITORS FROM PLURIPOTENT STEM CELLS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2023-05-25 — — US disclosed
US-20220348877-A1 GENERATION OF QUIESCENT CARDIAC FIBROBLASTS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS FOR IN VITRO MODELING OF CARDIAC FIBROSIS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2022-11-03 — — US disclosed
EP-3104873-B1 FGF-8 FOR USE IN TREATING DISEASES OR DISORDERS OF ENERGY HOMEOSTASIS UNIV MUENCHEN TECH (DE) 2019-09-04 — — EP disclosed
US-20170258874-A1 FGF-8 FOR USE IN TREATING DISEASES OR DISORDERS OF ENERGY HOMEOSTASIS Technische Universität München (DE) 2017-09-14 — — US disclosed
EP-3104873-A1 FGF-8 FOR USE IN TREATING DISEASES OR DISORDERS OF ENERGY HOMEOSTASIS Technische Universität München (DE) 2016-12-21 — — EP disclosed
WO-2015121457-A1 FGF-8 FOR USE IN TREATING DISEASES OR DISORDERS OF ENERGY HOMEOSTASIS WESTPHAL SÖREN (DE) 2015-08-20 — — WO disclosed
Send feedback